Compass Pathways plc - ADR Logo

Compass Pathways plc - ADR (CMPSN)

BMV

Currency in MXN
240.00
0.00 (0.00%)

Closed

Oct 6, 2026

Day's Range

240.00
240.00

52 wk Range

94.00
242.00

Overview - CMPSN - Compass Pathways plc - ADR

Key Statistics

Valuation

Enterprise Value

601.39B

P/E (Trailing)

‪-77.92‬

PEG Ratio

‪-0.21‬

Price / Book

‪21.30‬

EV / EBITDA

‪-177.06‬

Profitability

Profit Margin

‪0.00%‬

Operating Margin

‪0.00%‬

Return on Assets

‪-29.08%‬

Return on Equity

‪-319.06%‬

Ownership

Shares Outstanding

134.94M

Float

106.96M

Held by Insiders

‪7.62%‬

Held by Institutions

‪68.55%‬

Price stats

Beta

‪2.54‬

50-Day Avg

‪241.40‬

200-Day Avg

‪176.44‬

Dividends

Payout Ratio

‪0.00%‬

News Teaser - CMPSN - Compass Pathways plc - ADR

News & Analysis

View all news

Market Cap - CMPSN - Compass Pathways plc - ADR

Peers - CMPSN - Compass Pathways plc - ADR

Peer Comparison

Compared with companies in Medical Care Facilities listed on BMV.

Profile Summary - CMPSN - Compass Pathways plc - ADR

About

Compass Pathways plc - ADR is a clinical-stage biotechnology company focused on mental health care. Compass Pathways develops COMP360, a proprietary synthetic psilocybin therapy being studied for treatment-resistant depression and other psychiatric conditions, including post-traumatic stress disorder and anorexia…

SectorHealthcare
IndustryMedical Care Facilities
Employees166
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.